rs587776760
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_000387.6(SLC25A20):c.84delT(p.His29ThrfsTer100) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000622 in 1,606,756 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_000387.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC25A20 | ENST00000319017.5 | c.84delT | p.His29ThrfsTer100 | frameshift_variant | Exon 1 of 9 | 1 | NM_000387.6 | ENSP00000326305.4 | ||
SLC25A20 | ENST00000430379.5 | c.84delT | p.His29ThrfsTer87 | frameshift_variant | Exon 1 of 7 | 3 | ENSP00000388986.1 | |||
SLC25A20 | ENST00000440964.1 | n.84delT | non_coding_transcript_exon_variant | Exon 1 of 10 | 2 | ENSP00000388563.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000424 AC: 1AN: 236062Hom.: 0 AF XY: 0.00000778 AC XY: 1AN XY: 128578
GnomAD4 exome AF: 0.00000550 AC: 8AN: 1454508Hom.: 0 Cov.: 31 AF XY: 0.00000691 AC XY: 5AN XY: 723132
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74382
ClinVar
Submissions by phenotype
Carnitine acylcarnitine translocase deficiency Pathogenic:3
Variant summary: SLC25A20 c.84delT (p.His29ThrfsX100) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant allele was found at a frequency of 4.2e-06 in 236062 control chromosomes (gnomAD). c.84delT has been reported in the literature in individuals affected with Carnitine-Acylcarnitine Translocase Deficiency (e.g. Ogawa_2000, Hsu_2001). These data indicate that the variant is likely to be associated with disease. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. -
- -
This sequence change creates a premature translational stop signal (p.His29Thrfs*100) in the SLC25A20 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC25A20 are known to be pathogenic (PMID: 25614308). This variant is present in population databases (rs587776760, gnomAD 0.002%). This premature translational stop signal has been observed in individual(s) with carnitine-acylcarnitine translocase deficiency (PMID: 10697964, 11592821). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is also known as 120delT and 146delT. ClinVar contains an entry for this variant (Variation ID: 12136). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The c.84delT mutation in the SLC25A20 gene has been reported previously in association with carnitine-acylcarnitine translocase (CACT) deficiency using alternate nomenclature (Ogawa et al., 2000). The deletion causes a frameshift starting with codon Histidine 29, changes this amino acid to a Threonine residue and creates a premature Stop codon at position 100 of the new reading frame, denoted p.His29ThrfsX100. This mutation is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The variant is found in SLC25A20 panel(s). -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at